ARTICLE | Clinical News
FDA approves Prexxartan to treat hypertension
January 5, 2018 8:43 PM UTC
Medicure Inc. (TSX-V:MPH; PINK:MCUJF) said FDA granted final approval to an NDA from Carmel Biosciences Inc. (Atlanta, Ga.) for Prexxartan valsartan oral solution to treat hypertension in patients ages six and older, heart failure and stable left ventricular failure or left ventricular dysfunction after myocardial infarction. The small molecule angiotensin II type 1 receptor antagonist already had tentative approval from the agency...
BCIQ Target Profiles